Northeast Financial Consultants’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.4K | Hold |
|
|||||
|
2025
Q1 | $85.4K | Hold |
|
|||||
|
2024
Q4 | $88.3K | Hold |
|
|||||
|
2024
Q3 | $118K | Hold |
|
|||||
|
2024
Q2 | $121K | Hold |
|
|||||
|
2024
Q1 | $142K | Hold |
|
|||||
|
2023
Q4 | $109K | Buy |
|
|||||
|
2023
Q3 | $72.2K | Hold |
|
|||||
|
2023
Q2 | $93K | Hold |
|
|||||
|
2023
Q1 | $86.3K | Hold |
|
|||||
|
2022
Q4 | $93K | Buy |
|
|||||
|
2022
Q3 | $60K | Hold |
|
|||||
|
2022
Q2 | $78K | Hold |
|
|||||
|
2022
Q1 | $121K | Hold |
|
|||||
|
2021
Q4 | $146K | Buy |
|
|||||
|
2021
Q3 | $78K | Buy |
|
|||||
|
2021
Q2 | $49K | Hold |
|
|||||
|
2021
Q1 | $25K | Buy |
|